Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

QIAGEN showcases QIAsprint Connect, its first high-throughput benchtop automation system

By R&D Editors | February 10, 2026

After teasing it late last year, QIAGEN displayed the QIAsprint Connect at SLAS 2026 in Boston, marking the company’s entry into high-throughput benchtop sample-prep automation for research labs. The system processes up to 192 samples per run with minimal manual intervention and fits a compact benchtop footprint.

The platform supports both QIAGEN-tested and fully customizable protocols through a touch-based interface and modular chemistry design. It supports data-integrity and cybersecurity requirements, including 21 CFR Part 11 readiness. QIAGEN is also emphasizing sustainability: the QIAsprint consumables kits reduce plastic use by up to 50% and cut packaging volume by 40%.

“QIAsprint Connect is designed to help labs meet those demands and reflects QIAGEN’s strategy to expand automation across all throughput needs,” said Nitin Sood, SVP and Head of Product Portfolio & Innovation at QIAGEN.

QIAsprint Connect is part of a broader three-tier automation push showcased at the conference, with all three systems planned for launch in 2026. QIAGEN also showed QIAsymphony Connect, a next-generation clinical extraction platform for high-yield DNA/RNA isolation with complete sample tracking and standardized workflows, and QIAmini, a compact walkaway system aimed at lower-throughput labs looking for an entry point into automation.

QIAsprint Connect — Key Specs
Throughput Up to 192 samples/run
Protocols QIAGEN-tested + fully customizable
Compliance 21 CFR Part 11–ready
Sustainability Up to 50% less plastic, 40% less packaging volume
Form factor Compact benchtop

The three-system portfolio—QIAmini, QIAsprint Connect, QIAsymphony Connect—gives QIAGEN a throughput ladder from low-volume walkaway prep through clinical-scale extraction. It’s the company’s most significant automation hardware refresh in several years and aligns with QIAGEN’s stated goal of at least $2 billion in combined annual pillar sales in 2028.

Press release February 3, 2026; live unveil at SLAS 2026, Boston, February 7–11.

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Atinary launches its first self-driving lab in Boston
Molecular Devices and Automata partner to connect lab instruments end-to-end
Automata raises $45M to scale lab automation platform, adds Danaher as strategic investor
The lab OS wars: 15 companies vying to enable AI-enabled labs at SLAS 2026
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE